Abstract
Drug-induced interstitial lung diseases present with a variety of tissue reaction, most of them already discussed in previous chapters. A common presentation is diffuse alveolar damage as an acute reaction, often followed by organizing DAD, where hyaline membranes can still be recognized, and finally ending as organizing pneumonia and lung fibrosis. Other drugs induce NSIP-like tissue reactions. The major problem in interpreting drug reaction in the lung is our limited understanding of drug metabolism. Some drugs will induce toxic injury of endothelial cells, thus the blood barrier is leaking, and proteins can enter the interstitium and finally the alveolar lumen. Here these proteins will form complexes and by the action of respiration hyaline membranes will form. In addition the exudate from the capillaries will cause a transient edema and this is followed by hypoxia affecting the pneumocytes. This damage will contribute to DAD development (Fig. 14.1). Later on organizing pneumonia can result. Other drugs act on the immune system, forming immune complexes either because they are immunogenic by themselves or by complexing with endogenous proteins like a hapten. In these cases a NSIP or LIP pattern can result. In these cases scattered eosinophils are regularly found. Rarely granulomas are formed, usually pointing to an underlying immune mechanism. Since our understanding is so limited and no systematic experimental investigation has been performed, we still need to rely on databases, summarizing all described drug reactions in a systematic way (www.pneumotox.com; [1–8]).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Beinert T, Binder D, Stuschke M, Jorres RA, Oehm C, Fleischhacker M, Sezer O, Mergenthaler HG, Werner T, Possinger K. Oxidant-induced lung injury in anticancer therapy. Eur J Med Res. 1999;4:43–53.
Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev. 2002;34:791–820.
Cohen GM. Pulmonary metabolism of foreign compounds: its role in metabolic activation. Environ Health Perspect. 1990;85:31–41.
Dinsdale D. Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins. Int J Exp Pathol. 1995;76:393–401.
Garrido M, O’Brien A, Gonzalez S, Clavero JM, Orellana E. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest. 2007;132:1997–9.
Gupta S, Mahipal A. Fatal pulmonary toxicity after a single dose of cyclophosphamide. Pharmacotherapy. 2007;27:616–8.
Kameda H, Okuyama A, Tamaru J, Itoyama S, Iizuka A, Takeuchi T. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol. 2007;26:1585–9.
Myers J, El-Zammar O. Pathology of drug-induced lung disease; In: Katzenstein AL. Surgical pathology of non-neoplastic lung disease. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: Saunders Elsevier; 2006. pp 81–111.
Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13–22.
Downing L, Sawarynski KE, Li J, McGonagle M, Sims MD, Marples B. A simple quantitative method for assessing pulmonary damage after x irradiation. Radiat Res. 2010;173:536–44.
Faruqi S, Giuliani ME, Raziee H, Yap ML, Roberts H, Le LW, Brade A, Cho J, Sun A, Bezjak A, Hope AJ. Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2014;89:1076–83.
Crestani B, Kambouchner M, Soler P, Crequit J, Brauner M, Battesti JP, Valeyre D. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J. 1995;8:318–21.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Popper, H. (2017). Iatrogenic Lung Diseases. In: Pathology of Lung Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50491-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-50491-8_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-50489-5
Online ISBN: 978-3-662-50491-8
eBook Packages: MedicineMedicine (R0)